Cure – Clinical Trials and Cases
Cure — Clinical Trials and Cases
Before testing an agent or therapeutic approach in human subjects, researchers first need to show proof of concept or characterize how the agent behaves in vitro—in the laboratory. amfAR-funded researchers are testing a variety of approaches, such as boosting the immune system, gene therapy, and CAR T cells, which have proven highly successful in the treatment of certain types of cancer.
2024
Rejuvenating the Field of AIDS Research
Enhancing Innate Immunity Against HIV
2023
New Case of Post-Treatment Control
New Case of Possible HIV Cure Reported
Solving the Puzzle of Post-Treatment Control
amfAR Cure Trial Shows Proof of Concept
Confirmed: Düsseldorf Patient Cured of HIV
How Do Some People Control HIV Without Antiretroviral Therapy?
2022
Blocking T-Cell Growth: Will It Shrink the Reservoir?
Meet the London Patient: Adam Castillejo
The Issue of Tissue: Getting to the Source of the HIV Reservoir
Shock-and-Kill Trial Falls Short
Researchers Report Potential New Case of HIV Cure
2021
Stem Cell Transplants and the CCR5 Mutation
Researchers Report New Case of Spontaneous HIV Cure
Why Do Some Elite Controllers Stop Controlling HIV?
Reversing HIV Latency and Decreasing the Viral Reservoir: Clues from Cancer
Risks and Potential Benefits of Participating in Cure Research
2020
A Conversation with the San Francisco Patient
Research Update: Pioneering Clinical Trial Gets Underway
How Does the Immune System Recover After a Stem Cell Transplant?
Why Do HIV Reservoirs Persist After Stem Cell Transplants?
2019
amfAR Researchers Unable to Find HIV In London Transplant Patient